Home/CaroGen/Michael Robek, Ph.D.

MR

Michael Robek, Ph.D.

Member, Scientific Advisory Board

Therapeutic Areas

Oncology Infectious Diseases

CaroGen Pipeline

Drug	Indication	Phase
CARG-2020	Ovarian Cancer	Pre-clinical
CARG-201	Chronic Hepatitis B (CHB)	Pre-clinical

Leadership Team at CaroGen

Bijan Almassian, Ph.D.

Chief Executive Officer

Valerian Nakaar, Ph.D.

Chief Scientific Officer

John Rose, Ph.D.

Chairman, Scientific Advisory Board

View full CaroGen profile